Novel S1P1 Receptor Agonists - Part 2: From Bicyclo[3.1.0]hexane-Fused Thiophenes to Isobutyl Substituted Thiophenes

被引:13
作者
Bolli, Martin H. [1 ]
Velker, Joerg [1 ]
Mueller, Claus [1 ]
Mathys, Boris [1 ]
Birker, Magdalena [1 ]
Bravo, Roberto [1 ]
Bur, Daniel [1 ]
de Kanter, Ruben [1 ]
Hess, Patrick [1 ]
Kohl, Christopher [1 ]
Lehmann, David [1 ]
Meyer, Solange [1 ]
Nayler, Oliver [1 ]
Rey, Markus [1 ]
Scherz, Michael [1 ]
Steiner, Beat [1 ]
机构
[1] Actel Pharmaceut Ltd, Drug Discovery Chem, CH-4123 Allschwil, Switzerland
关键词
SPHINGOSINE 1-PHOSPHATE RECEPTOR; LYMPHOCYTE EGRESS; LYMPHATIC TRANSPORT; IN-VITRO; T-CELLS; SPHINGOSINE-1-PHOSPHATE; FTY720; POTENT; DRUG; DISCOVERY;
D O I
10.1021/jm401456d
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Previously, we reported on the discovery of a novel series of bicyclo[3.1.0]hexane fused thiophene derivatives that serve as potent and selective S1P(1), receptor agonists. Here, we discuss our efforts to simplify the bicyclohexane fused thiophene head. In a first step the bicyclohexane moiety could be replaced by a simpler, less rigid cyclohexane ring without compromising the SIP receptor affinity profile of these novel compounds. In a second step, the thiophene head was simplified even further by replacing the cyclohexane ring with an isobutyl group attached either to position 4 or position S of the thiophene. These structurally much simpler headgroups again furnished potent and selective S1P(1) agonists (e.g., 87), which efficiently and dose dependently reduced the number of circulating lymphocytes upon oral administration to male Wistar rats. For several compounds discussed in this report lymphatic transport is an important route of absorption that may offer opportunities for a tissue targeted approach with minimal plasma exposure.
引用
收藏
页码:78 / 97
页数:20
相关论文
共 107 条
[1]   DESIGN, SYNTHESIS, AND STRUCTURE-ACTIVITY-RELATIONSHIPS OF 2-SUBSTITUTED-2-AMINO-1,3-PROPANEDIOLS - DISCOVERY OF A NOVEL IMMUNOSUPPRESSANT, FTY720 [J].
ADACHI, K ;
KOHARA, T ;
NAKAO, N ;
ARITA, M ;
CHIBA, K ;
MISHINA, T ;
SASAKI, S ;
FUJITA, T .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1995, 5 (08) :853-856
[2]   Fingolimod is a potential novel therapy for multiple sclerosis [J].
Aktas, Orhan ;
Kuery, Patrick ;
Kieseier, Bernd ;
Hartung, Hans-Peter .
NATURE REVIEWS NEUROLOGY, 2010, 6 (07) :373-382
[3]   REGIOSELECTIVE SYNTHESIS OF 2-FUNCTIONALIZED THIOPHENES BY CONDENSATION OF ALPHA-MERCAPTO COMPOUNDS WITH BETA-AMINOENONE DERIVATIVES [J].
ALBEROLA, A ;
ANDRES, JM ;
GONZALEZ, A ;
PEDROSA, R ;
PRADANOS, P .
SYNTHETIC COMMUNICATIONS, 1990, 20 (16) :2537-2547
[4]   Cardiovascular effects of sphingosine-1-phosphate and other sphingomyelin metabolites [J].
Alewijnse, AE ;
Peters, SLM ;
Michel, MC .
BRITISH JOURNAL OF PHARMACOLOGY, 2004, 143 (06) :666-684
[5]   Sphingolipid signalling in the cardiovascular system: Good, bad or both? [J].
Alewijnse, Astrid E. ;
Peters, Stephan L. M. .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2008, 585 (2-3) :292-302
[6]   Expression of the sphingosine 1-phosphate receptor, S1P1, on T-cells controls thymic emigration [J].
Allende, ML ;
Dreier, JL ;
Mandala, S ;
Proia, RL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (15) :15396-15401
[7]   AN ASYMMETRIC SIMMONS-SMITH REACTION [J].
ARAI, I ;
MORI, A ;
YAMAMOTO, H .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1985, 107 (26) :8254-8256
[8]  
Armarego WLF, 2009, PURIFICATION OF LABORATORY CHEMICALS, 6TH EDITION, P1
[9]   Sphingomyelin metabolites in vascular cell signaling and atherogenesis [J].
Augé, N ;
Nègre-Salvayre, A ;
Salvayre, R ;
Levade, T .
PROGRESS IN LIPID RESEARCH, 2000, 39 (03) :207-229
[10]  
Baumruker Thomas, 2006, Current Immunology Reviews, V2, P101, DOI 10.2174/157339506775471929